A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation

Trial Profile

A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2014

At a glance

  • Drugs Axelopran (Primary)
  • Indications Constipation
  • Focus Adverse reactions
  • Sponsors Theravance
  • Most Recent Events

    • 26 Apr 2013 Results will be presented at the 32nd Annual Scientific Meeting of the American Pain Society (APS) in May 2013.
    • 26 Apr 2013 Status changed from active, no longer recruiting to completed, as indicated in a Theravance media release.
    • 06 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top